Correlation Between ImmuCell and Pure Bioscience

Can any of the company-specific risk be diversified away by investing in both ImmuCell and Pure Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuCell and Pure Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ImmuCell and Pure Bioscience, you can compare the effects of market volatilities on ImmuCell and Pure Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuCell with a short position of Pure Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuCell and Pure Bioscience.

Diversification Opportunities for ImmuCell and Pure Bioscience

-0.57

Correlation Coefficient

ImmuCell  Pure Bioscience

Excellent diversification

The 3 months correlation between ImmuCell and Pure is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding ImmuCell and Pure Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pure Bioscience and ImmuCell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuCell are associated (or correlated) with Pure Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pure Bioscience has no effect on the direction of ImmuCell i.e., ImmuCell and Pure Bioscience go up and down completely randomly.

Pair Corralation between ImmuCell and Pure Bioscience

If you would invest  429.00  in ImmuCell on October 7, 2024 and sell it today you would earn a total of  86.00  from holding ImmuCell or generate 20.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	0.79%
Values	Daily Returns

ImmuCell  vs.  Pure Bioscience

ImmuCell

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in ImmuCell are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile fundamental indicators, ImmuCell exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pure Bioscience

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pure Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Pure Bioscience is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with ImmuCell and Pure Bioscience

The main advantage of trading using opposite ImmuCell and Pure Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuCell position performs unexpectedly, Pure Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pure Bioscience will offset losses from the drop in Pure Bioscience's long position.

The idea behind ImmuCell and Pure Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.